We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Insight Enterprises
NSIT
$3.55B
| $2.95M | 0.01% |
98,504
-4,053
| -4% | -$120K |
|
1302
Materion
MTRN
$5.01B
| $2.94M | 0.01% |
83,505
-2,229
| -3% | -$85.9K |
|
1303
Old National Bancorp
ONB
$10.1B
| $2.94M | 0.01% |
203,447
+17,712
| +10% | +$249K |
|
|
MON
1304
DELISTED
Monsanto Co
MON
| $2.94M | 0.01% |
27,604
+10,337
| +60% | +$1.2M |
|
1305
MillerKnoll
MLKN
$1.5B
| $2.94M | 0.01% |
+101,511
| New | +$2.89M |
|
|
SPTN
1306
DELISTED
SpartanNash
SPTN
| $2.94M | 0.01% |
90,250
-12,402
| -12% | -$397K |
|
1307
World Acceptance Corp
WRLD
$950M
| $2.93M | 0.01% |
47,641
+6,287
| +15% | +$500K |
|
1308
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
| $2.93M | 0.01% |
45,404
-2,188
| -5% | -$144K |
|
|
VER
1309
DELISTED
VEREIT, Inc.
VER
| $2.92M | 0.01% |
71,957
-21,142
| -23% | -$954K |
|
1310
BJ's Restaurants
BJRI
$1.41B
| $2.92M | 0.01% |
60,341
-4,335
| -7% | -$209K |
|
1311
Blackbaud
BLKB
$1.5B
| $2.92M | 0.01% |
51,256
+14,880
| +41% | +$777K |
|
1312
Matrix Service
MTRX
$347M
| $2.92M | 0.01% |
159,459
+67,952
| +74% | +$1.33M |
|
1313
Darling Ingredients
DAR
$9.93B
| $2.91M | 0.01% |
198,297
+162,266
| +450% | +$2.39M |
|
1314
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
| $2.9M | 0.01% |
+74,177
| New | +$2.99M |
|
1315
Comscore
SCOR
| $2.9M | 0.01% |
2,718
+161
| +6% | +$174K |
|
1316
Skywest
SKYW
$4.11B
| $2.89M | 0.01% |
192,258
-7,611
| -4% | -$114K |
|
|
DRII
1317
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $2.89M | 0.01% |
91,589
-969
| -1% | -$31.6K |
|
|
THS
1318
DELISTED
Treehouse Foods
THS
| $2.89M | 0.01% |
35,621
-23,959
| -40% | -$1.85M |
|
|
HME
1319
DELISTED
HOME PROPERTIES, INC
HME
| $2.87M | 0.01% |
39,284
+9,946
| +34% | +$722K |
|
1320
Matthews International
MATW
$864M
| $2.87M | 0.01% |
53,997
+17,457
| +48% | +$890K |
|
1321
Coherent
COHR
$55.2B
| $2.86M | 0.01% |
150,495
-90,085
| -37% | -$1.68M |
|
|
ORAN
1322
DELISTED
Orange
ORAN
| $2.85M | 0.01% |
185,886
+5,572
| +3% | +$89.9K |
|
|
LDL
1323
DELISTED
Lydall, Inc.
LDL
| $2.85M | 0.01% |
96,501
-3,174
| -3% | -$91.9K |
|
|
EFOR
1324
Everforth Inc
EFOR
$845M
| $2.85M | 0.01% |
72,538
+36,776
| +103% | +$1.4M |
|
1325
Ametek
AME
$55.5B
| $2.84M | 0.01% |
51,767
+32,669
| +171% | +$1.75M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.